Q When did you start work on a new vaccine and what is the status of the research?
A. We began work on the new vaccine, CoroFlu, in February this year. CoroFlu builds on cutting-edge technology from an influenza vaccine already being developed by US company FluGen, and based on research at the University of Wisconsin, Madison (UWM). Because CoroFlu is based on a flu vaccine, our team hopes to protect patients from both the flu virus and the novel coronavirus at the same time.